Shareholders
Shareholders
Top 10 shareholders as of June 31, 2022
| Name | Number of shares | Ownership in pct |
|---|---|---|
| Redmile Group, LLC | 5 380 863 | 12.1% |
| Fjärde AP-Fonden (AP 4) | 2 207 397 | 4.9% |
| Nexttobe AB | 2 155 379 | 4.8% |
| Invesco Advisers, Inc. | 1 973 931 | 4.4% |
| Olausson, Thomas | 1 820 500 | 4.1% |
| Försäkrings AB Avanza Pension | 1 743 201 | 4.0% |
| Tredje AP-Fonden (AP 3) | 1 389 650 | 3.1% |
| The Vanguard Group, Inc. | 1 223 839 | 2.7% |
| Schroder Investment Management, LTD | 888 132 | 2.0% |
| C WorldWide Asset Management | 799 749 | 1.8% |
| Other | 25 005 477 | 56.1% |
| Outstanding shares in total | 44,588,118 | 100.0% |
Source: IHS Markit/IPREO compiled and processed data from various sources, including Euroclear, Morningstar, Factset and the Swedish Financial Supervisory Authority (Finansinspektionen).
Hansa Biopharma had approximately 18,000 shareholders as of March 31, 2022.
Classification of ownership as per Dec 31, 2021
Region
60%
23%
13%
4%
Category
50%
35%
10%
5%